Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Chinese Patent Office
Covington
Mallinckrodt
Colorcon
Johnson and Johnson
Citi
Daiichi Sankyo
US Department of Justice

Generated: February 22, 2018

DrugPatentWatch Database Preview

Rubidium chloride rb-82 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rubidium chloride rb-82 and what is the scope of rubidium chloride rb-82 freedom to operate?

Rubidium chloride rb-82
is the generic ingredient in two branded drugs marketed by Bracco and Jubilant Draximage, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for rubidium chloride rb-82. Two suppliers are listed for this compound.
Pharmacology for rubidium chloride rb-82

US Patents and Regulatory Information for rubidium chloride rb-82

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Draximage RUBY-FILL rubidium chloride rb-82 SOLUTION;INTRAVENOUS 202153-001 Sep 30, 2016 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for rubidium chloride rb-82

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Accenture
Covington
Deloitte
Harvard Business School
Fuji
Moodys
Teva
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot